In sports medicine, the holy grail for anterior cruciate ligament reconstruction (ACLR) is simple: less pain, faster recovery ...

Orthofix Medical, Inc. reported $203.121 million in sales and ($16,003) million in operating losses for the quarter ending ...

In spine surgery, measuring success isn’t always as simple as “X-rays look straighter, job well done.” Deformity surgeons ...

In June 2025, Cerapedics secured FDA premarket approval for its PearlMatrix™ P-15 Peptide Enhanced Bone Graft.

Integra LifeSciences Holdings Corporation reported $415.6 million in sales and ($512.674) million in operating losses for the ...

According to a new meta-analysis in the July 13, 2025, Journal of Experimental Orthopaedics, you’ll need to perform somewhere ...

CONMED’s 2Q25 numbers are in, and the picture is a mix of solid topline growth, orthopedic momentum, and some capital-market ...

A new systematic review and meta-analysis in The Journal of Bone and Joint Surgery (July 29, 2025) is asking a question that ...

Stryker Corporation is in growth mode—again. In its Q2 2025 earnings call, CEO Kevin Lobo and VP of Finance and Investor ...

It's time to stop casually watching Alphatec Holdings, Inc. and start paying attention—they're not just growing, they’re ...

In an industry where everyone talks about “disrupting” spine, Demetra Holding S.p.A. might actually be doing it.

In the land of blues, barbecue, and biomedical hustle, Memphis is turning up the volume on medtech innovation.